AI
PACB icon

Atria Investments’s Pacific Biosciences PACB Stock Holding History

Atria Investments’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,496
Closed -$51.4K – 2125
2025
Q4 		$51.4K Buy
27,496
+5,735
+26% +$11K ﹤0.01% 2015
2025
Q3 		$27.9K Sell
21,761
-410
-2% -$555 ﹤0.01% 2002
2025
Q2 		$27.5K Sell
22,171
-157
-0.7% -$181 ﹤0.01% 1981
2025
Q1 		$26.3K Sell
22,328
-3,926
-15% -$6.02K ﹤0.01% 1889
2024
Q4 		$48K Buy
26,254
+4,286
+20% +$8.37K ﹤0.01% 1842
2024
Q3 		$37.3K Buy
21,968
+10,138
+86% +$16.7K ﹤0.01% 1892
2024
Q2 		$16.2K Buy
+11,830
New +$23.9K ﹤0.01% 1904

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return